Training Courses
Keep up to date with emerging research techniques, technology developments and regulatory changes by attending one of our training courses, short courses and workshops.

Organ-on-a-Chip: Technologies and Applications


Held in conjunction with Organ-on-a-Chip, Tissue-on-a-Chip Europe 2018

04 Jun 2018, at 16:30-19:00 in Rotterdam, The Netherlands

Price:






James Hickman, Professor, University of Central Florida



Scope

This Training Course presented in tandem with the SELECTBIO Organ-on-a-Chip Europe 2018 Conference provides an interactive presentation and discussion of the technology platforms, methodologies, as well as application areas in the exciting space that is created by the deployment of microfluidics and lab-on-a-chip technologies for creating "organs-on-chips" (or sometimes referred to as "body-on-a-chip").

Referred to as "Microscale systems", there are several classes of organs-on-chips which have been built including:

  • Lung-on-a-Chip
  • Liver-on-a-Chip
  • Brain-on-a-Chip
  • Gut-on-a-Chip
  • Marrow-on-a-Chip
  • Nerve-on-a-Chip
  • Disease-on-a-Chip
Topics Addressed in this Training Course
  • Overview of the Opportunity:  Why would Microscale Systems ("Organs-on-Chips") be Useful for Drug Development?
  • Physiologically-based Pharmacokinetic/Pharmacodynamic Models as a Guide to Develop Model Systems (Microphysiological Systems)
  • Brief Overview of Microfluidics
  • Organ-on-a-Chip Systems: Concepts, Uses and Limitations plus Examples
  • Body-on-a-Chip (or Microphysiological Systems): Integrating Organs-on-a-Chip to build Surrogates for Drug Development

All Course Delegates Receive the Electronic Copies of the Presentations Plus Publications and Up-to-Date Reviews on this Field to Bring Back and Use as Reference Material for R&D Planning/Presentations, Business Plans and Investor Presentations. This course includes a networking reception for all delegates at the end of the course, and offers excellent discussion opportunities whereby delegates can explores the science as well as market opportunities in the organ-on-a-chip field.